Congressional Briefing Highlights Importance of Alternatives to Animal Models August 27, 2021 Share More from the Blog Developing More Clinically Relevant Drug-Induced Thrombosis Models Read More Charting Our Path Forward: Determination and Resilience Attracts $82M Series E Funding Read More Studying Gut Inflammation and Barrier Disruption with Organ-on-a-Chip Technology Read More Browse All